← Leaderboards
Michael A Morse
Duke University
$2,384,223
Attributed
$2,384,223
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $521K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$2,384,223 · 3
By mechanism
P01$1,252,901 · 1
R21$1,131,322 · 2
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Herbert Kim Lyerly$48,598,090
- Dorothy A Sipkins$8,543,606
- Nenad Bursac$22,509,345
- Dwight D Koeberl$10,403,079
- Andrea Na Amalfitano$3,802,601
Others in their field
Top investigators on “Tumor Antigens”
- William R Green · Dartmouth College$32,738,211
- John H Sampson · Duke University$30,849,602
- Catherine Ju-Ying Wu · Broad Institute, Inc.$30,485,072
- Elizabeth Marion Jaffee · Johns Hopkins University$26,862,085
- Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$24,066,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
Research focus
Tumor AntigensImmune ResponseNeoplasm /Cancer ImmunotherapyEnzyme Linked Immunosorbent AssayDendritic CellsBaseIn VitroMalignant NeoplasmsImmunizationAntigensEnzyme Linked Immunospot AssayCarcinoembryonic AntigenCd58 GeneCd80 GeneImmunologicsFowlpox VectorCytokineFrequencies (Time Pattern)Clinical Trials, Phase IIcam1 GeneClinical ResearchClinical Trials, Phase IiHuman SubjectInterleukin-2
Grant awards (9)
Active Immunotherapy with Pox Vector Modified DC$305,579
P01 · FY2008 · CA · contact PI
Active Immunotherapy with Pox Vector Modified DC$306,513
P01 · FY2007 · CA · contact PI
Vaccination with Regulatory T Cell Depletion$214,482
R21 · FY2007 · CA · contact PI
Vaccination with Regulatory T Cell Depletion$220,342
R21 · FY2006 · CA · contact PI
Active Immunotherapy with Pox Vector Modified DC$218,073
P01 · FY2006 · CA · contact PI
Active Immunotherapy with Pox Vector Modified DC$213,630
P01 · FY2005 · CA
Active Immunotherapy with Pox Vector Modified DC$209,106
P01 · FY2004 · CA
DEXASOME BASED IMMUNOTHERAPY OF LUNG CANCER$348,249
R21 · FY2002 · CA
DEXASOME BASED IMMUNOTHERAPY OF LUNG CANCER$348,249
R21 · FY2001 · CA